Cancer BiologybioRxivPreprint
Context-specific GITR agonism potentiates anti-PD-L1 and CD40-based immuno- chemotherapy combination in heterogeneous pancreatic tumors
Chanthirika Ragulan, Krisha Desai, Patrick Varun Lawrence…·Anguraj Sadanandam
This study identifies GITR agonism as a potential enhancer of anti-PD-L1 and CD40-based immunotherapy in pancreatic tumors by targeting immune evasion mechanisms.
4 citations